November 11th 2025

By Ailsa Colquhoun

Alert: Emylif 50mg orodispersible film

One batch of Emylif 50mg orodispersible film is being recalled as a precautionary measure. This is due to concerns about impurities at 24 months’ shelf life.

The affected batch is as follows:

Emylif films will now be labelled with an 18-month shelf life. Previously, they were licensed with a 36-month shelf life.  

Healthcare teams are asked to quarantine all stock from this batch and return it to your supplier using your supplier’s approved process.

Patients should continue to take medicines from batch C24QA104 as prescribed by the healthcare professional. This batch will remain within specification limits until 30 April 2026.